Approach

Unlocking Lipid Biology for GI Diseases

Our proprietary platform technology transforms lipids with established efficacy and safety into novel salts to overcome the formulation and IP hurdles that have limited the development of bioactive lipids as pharmaceutical drugs in the GI arena.


 

 

Lipid Biology
 

+

 

HEALER™ Platform
 

+

 

Intellectual Property
 

=

 

High-Value Candidates